Skip to main content
Clinical Trials/DRKS00005289
DRKS00005289
Completed
未知

Study on the evaluation of hippotherapy in the course of treatment for multiple sclerosis - a prospective, randomized controlled and multicenter study - MS-Hippo

Zentrum für Therapeutisches Reiten Johannisberg e.V.0 sites70 target enrollmentOctober 9, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
G35
Sponsor
Zentrum für Therapeutisches Reiten Johannisberg e.V.
Enrollment
70
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 9, 2013
End Date
July 3, 2014
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zentrum für Therapeutisches Reiten Johannisberg e.V.

Eligibility Criteria

Inclusion Criteria

  • Definite multiple sclerosis with spasticity of the lower limbs;
  • EDSS\-Score between 4 and 6\.5;
  • Presence of an informed consent form signed by the patient;
  • Consent of the responsible investigator;
  • Legal capacity;
  • Minimum age of 18 years

Exclusion Criteria

  • Hippotherapy within the last 12 months;
  • Parallel participation in other interventional studies;
  • Persons, who have an employment relationship/ a relationship of dependency on the sponsor or the investigator
  • Placing in an institution because of responsible governmental or judicial authorities;
  • Body weight above 90 kg;
  • Acute episode between 4 weeks prior to the start of the therapy;
  • No balance while sitting;
  • Planned start of an new spasmolytic drug or drugs, which could influence the tested parameters (for example Sativex®; Injection of Baclofen close to the spinal cord, 4\-Aminopyridin);
  • cerebral seizure disorder, that is not medically adjusted;
  • No or insufficient ability to spread out the legs, which is necessary to sit on a horse;

Outcomes

Primary Outcomes

Not specified

Similar Trials